Webinar: A Dissection of SARS-CoV-2 with Primary Human Lung Culture Systems
Join Pharma IQ and The Sartorius Group for an overview of the methods for human lung organoids and quantitative assessment of biological effects of the SARS-CoV-2 infection.
In this session, supported by The Sartorius Group, hosts Sandra Lawrynowicz Leibel, Assistant Professor of Pediatrics, and Ben Croker, Associate Professor, both at the University of California, San Diego (UCSD), will explore the latest cell culture methods for the current generation of human lung culture systems, as well as revealing what is required for a quantitative assessment of infection by SARS-CoV-2.
The industry experts will take a deep dive into an investigation of SARS-CoV-2 using human lung cell models, including air liquid interphase cultures of bronchial epithelial cells and human pluripotent stem cell. They will also explore derived lung organoids containing epithelial cells of the distal parenchyma (alveolar type 1 and 2 cells), upper airway (basal, ciliated and secretory cells), and stromal cells important in studying inflammatory epithelial-mesenchymal transitioning.
Join this session to discover:
- The latest cell culture methods for generation of human lung culture systems
- What is required for a quantitative assessment of infection by SARS-CoV-2
- How to carry out therapeutic testing for COVID-19 using human lung cells
- A dissection of SARS-CoV-2 variants using a permissive primary human cell type
- Why to use live cell imaging to investigate pathobiology of SARS-CoV-2 infection
About the speakers
Sandra Leibel, MD MSc
University of California, San Diego
Ben Croker, PhD
University of California, San Diego